Van WyckD.B., StivelmanJ.C., RuizJ., KirlinL.F., KatzM.A., OgdenD.A.Iron status in patients receiving erythropoietin for dialysis-associated anemia.Kidney Int1989; 35: 712–16.
2.
LevinN.M., LazarusJ.M., NissensonA.R.National cooperative recombinant human erythropoietin study in patients with chronic renal failure-an interim report.Am J Kidney Dis1993; 22(Suppl): 3–12.
3.
DomotoD.T., MartinK.J.Failure of CAPD patients to respond to an oral iron absorption test. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8: 102–4.
4.
TinawiM., MartinK.J., BastaniB.Oral iron absorption test in patients on CAPD: comparison of ferrous sulfate and a polysaccharide ferric complex.Nephron1996; 74: 291–4.
5.
LipschitzD.A., CookJ.D., FinchC.A.A clinical evaluation of serum ferritin as an index of iron stores.N EnglJ Med1974; 290: 1213–16.
6.
Kalantar-ZadehK., HoffkenB., WunschH., FinkH., KleinerM., LuftF.C.Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era.Am J Kidney Dis1995; 26: 292–9.
7.
Thirayo thinP., CrosbyW.H.The distribution of iron injected intraperitoneally. Evidence of serosal “absorption” by the small intestine.J Clin Invest1962; 41: 1206–10.
8.
RobinsonS.C.Observations on the peritoneum as an absorbing surface.AmJ ObstetGynecol1962; 81: 446–52.
9.
MehtaB.C., PateI.J.C.Total dose iron therapy using irondextran by intraperitoneal route.Indian J Med Sci1969; 23: 587–93.
